Direct transition to long-acting risperidone--analysis of long-term efficacy.

  title={Direct transition to long-acting risperidone--analysis of long-term efficacy.},
  author={Werner Kissling and Stephan Heres and Keith Lloyd and Emilio Sacchetti and Philippe Bouhours and Rossella Medori and Pierre Michel Llorca},
  journal={Journal of psychopharmacology},
  volume={19 5 Suppl},
This report presents data from the extension phase of a 6-month trial that evaluated the efficacy of risperidone long-acting injectable (RLAI) in stable psychotic patients requiring a treatment change. Patients continued to receive RLAI every 2 weeks for a maximum of 12 months from study entry. Symptoms were assessed using the PANSS after 1, 3, 6, 9 and 12 months of treatment (or treatment endpoint). Remission of severity criteria were defined as < or =3 points in all PANSS items suggested by… CONTINUE READING

From This Paper

Topics from this paper.
22 Citations
0 References
Similar Papers


Publications citing this paper.
Showing 1-10 of 22 extracted citations

Similar Papers

Loading similar papers…